semaglutide affect hormones and Menopause: Does It Work? Spotlight on the Mechanism of
Description
Eli Lilly quietly cancelled a clinical trial for an experimental drug to slow muscle loss in obesity patients taking its GLP-1 weight loss drug

Both are now widely prescribed for weight management under brand names most people recognize: Ozempic and Wegovy for semaglutide, Mounjaro and Zepbound for tirzepatide.

Four GLP-1 strategies are failing

Kidney data continue to mature

While synthetic GLP-1 receptor agonists (RAs) like semaglutide and tirzepatide dominate clinical use, plant-derived GLP-1 modulators present a promising alternative due to their natural origin, diverse mechanisms, and potential for reduced side effects
